Maven Securities’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-80,421
Closed -$514K 804
2025
Q1
$514K Buy
80,421
+50,421
+168% +$486K 0.02% 582
2024
Q4
$356K Buy
30,000
+15,000
+100% +$256K 0.01% 662
2024
Q3
$415K Buy
+15,000
New +$375K 0.01% 702
2024
Q2
Sell
-100,000
Closed -$1.76M 907
2024
Q1
$1.76M Buy
+100,000
New +$1.47M 0.1% 97
2023
Q4
Sell
-100,000
Closed -$860K 927
2023
Q3
$860K Buy
+100,000
New +$710K 0.01% 666

Other funds holding ASPN

Maven Securities's ASPN Position: Q2 2025 in Review

Maven Securities sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 80,421 shares — an estimated $514K sold.

Maven Securities first reported a position in ASPN in Q3 2023 and held it in 5 quarters. The position peaked at $1.76M in Q1 2024. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

  • Maven Securities reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
  • Maven Securities sold 80,421 Aspen Aerogels shares in Q2 2025, an estimated $514K.
  • Maven Securities first reported a position in Aspen Aerogels in Q3 2023 and held it in 5 quarters.
  • Maven Securities's Aspen Aerogels position peaked at $1.76M in Q1 2024.
  • 182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.